Appili Therapeutics Inc.
APLIF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,228 | $94 | $6,665 | $11,063 |
| Short-Term Investments | $0 | $0 | $0 | $5,062 |
| Receivables | $1,671 | $0 | $421 | $0 |
| Inventory | $0 | $0 | -$48 | $267 |
| Other Curr. Assets | $115 | $192 | $231 | $184 |
| Total Curr. Assets | $3,014 | $1,460 | $8,239 | $18,262 |
| Property Plant & Equip (Net) | $19 | $30 | $42 | $55 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $19 | $30 | $42 | $55 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,033 | $1,490 | $8,282 | $18,317 |
| Liabilities | – | – | – | – |
| Payables | $4,106 | $4,107 | $2,823 | $6,382 |
| Short-Term Debt | $11,558 | $7,310 | $113 | $96 |
| Tax Payable | $29 | $47 | $41 | $0 |
| Deferred Revenue | $0 | $0 | $0 | -$118 |
| Other Curr. Liab. | $0 | $76 | $0 | -$1,861 |
| Total Curr. Liab. | $15,694 | $11,540 | $6,669 | $4,617 |
| LT Debt | $736 | $875 | $4,883 | $947 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $2,669 | $3,936 |
| Total NC Liab. | $736 | $875 | $4,883 | $947 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $16,430 | $12,415 | $11,552 | $5,564 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $42,323 | $42,323 | $39,653 | $34,962 |
| Retained Earnings | -$71,718 | -$69,093 | -$56,069 | -$30,951 |
| AOCI | $0 | $0 | $9,179 | $8,132 |
| Other Equity | $15,997 | $15,845 | $18,262 | $5,013 |
| Total Equity | -$13,397 | -$10,925 | -$3,271 | $12,753 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,033 | $1,490 | $8,282 | $18,317 |
| Net Debt | $11,066 | $8,090 | -$1,669 | -$10,020 |